259 related articles for article (PubMed ID: 10699250)
1. The selectable marker human dihydrofolate reductase enables sequential genetic manipulation of the Plasmodium berghei genome.
de Koning-Ward TF; Fidock DA; Thathy V; Menard R; van Spaendonk RM; Waters AP; Janse CJ
Mol Biochem Parasitol; 2000 Mar; 106(2):199-212. PubMed ID: 10699250
[TBL] [Abstract][Full Text] [Related]
2. Complementation of Plasmodium berghei TRAP knockout parasites using human dihydrofolate reductase gene as a selectable marker.
Sultan AA; Thathy V; de Koning-Ward TF; Nussenzweig V
Mol Biochem Parasitol; 2001 Mar; 113(1):151-6. PubMed ID: 11254963
[TBL] [Abstract][Full Text] [Related]
3. Selection of drug resistant mutants from random library of Plasmodium falciparum dihydrofolate reductase in Plasmodium berghei model.
Tipsuwan W; Srichairatanakool S; Kamchonwongpaisan S; Yuthavong Y; Uthaipibull C
Malar J; 2011 May; 10():119. PubMed ID: 21554743
[TBL] [Abstract][Full Text] [Related]
4. High-efficiency transfection and drug selection of genetically transformed blood stages of the rodent malaria parasite Plasmodium berghei.
Janse CJ; Ramesar J; Waters AP
Nat Protoc; 2006; 1(1):346-56. PubMed ID: 17406255
[TBL] [Abstract][Full Text] [Related]
5. Identifying antimalarial compounds targeting dihydrofolate reductase-thymidylate synthase (DHFR-TS) by chemogenomic profiling.
Aroonsri A; Akinola O; Posayapisit N; Songsungthong W; Uthaipibull C; Kamchonwongpaisan S; Gbotosho GO; Yuthavong Y; Shaw PJ
Int J Parasitol; 2016 Jul; 46(8):527-35. PubMed ID: 27150044
[TBL] [Abstract][Full Text] [Related]
6. Transgenic Plasmodium parasites stably expressing Plasmodium vivax dihydrofolate reductase-thymidylate synthase as in vitro and in vivo models for antifolate screening.
Somsak V; Uthaipibull C; Prommana P; Srichairatanakool S; Yuthavong Y; Kamchonwongpaisan S
Malar J; 2011 Oct; 10():291. PubMed ID: 21981896
[TBL] [Abstract][Full Text] [Related]
7. Improved transfection and new selectable markers for the rodent malaria parasite Plasmodium yoelii.
Jongco AM; Ting LM; Thathy V; Mota MM; Kim K
Mol Biochem Parasitol; 2006 Apr; 146(2):242-50. PubMed ID: 16458371
[TBL] [Abstract][Full Text] [Related]
8. Stable transfection of malaria parasite blood stages.
van Dijk MR; Waters AP; Janse CJ
Science; 1995 Jun; 268(5215):1358-62. PubMed ID: 7761856
[TBL] [Abstract][Full Text] [Related]
9. Transformation of Plasmodium falciparum malaria parasites by homologous integration of plasmids that confer resistance to pyrimethamine.
Wu Y; Kirkman LA; Wellems TE
Proc Natl Acad Sci U S A; 1996 Feb; 93(3):1130-4. PubMed ID: 8577727
[TBL] [Abstract][Full Text] [Related]
10. Molecular epidemiology of malaria in Yaounde, Cameroon. VI. Sequence variations in the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene and in vitro resistance to pyrimethamine and cycloguanil.
Basco LK; Ringwald P
Am J Trop Med Hyg; 2000 Feb; 62(2):271-6. PubMed ID: 10813484
[TBL] [Abstract][Full Text] [Related]
11. Expression of a Plasmodium gene introduced into subtelomeric regions of Plasmodium berghei chromosomes.
van Dijk MR; Janse CJ; Waters AP
Science; 1996 Feb; 271(5249):662-5. PubMed ID: 8571132
[TBL] [Abstract][Full Text] [Related]
12. An amino acid substitution in the Babesia bovis dihydrofolate reductase-thymidylate synthase gene is correlated to cross-resistance against pyrimethamine and WR99210.
Gaffar FR; Wilschut K; Franssen FF; de Vries E
Mol Biochem Parasitol; 2004 Feb; 133(2):209-19. PubMed ID: 14698433
[TBL] [Abstract][Full Text] [Related]
13. Within-Host Selection of Drug Resistance in a Mouse Model of Repeated Incomplete Malaria Treatment: Comparison between Atovaquone and Pyrimethamine.
Nuralitha S; Siregar JE; Syafruddin D; Roelands J; Verhoef J; Hoepelman AI; Marzuki S
Antimicrob Agents Chemother; 2016 Jan; 60(1):258-63. PubMed ID: 26503662
[TBL] [Abstract][Full Text] [Related]
14. Puromycin-N-acetyltransferase as a selectable marker for use in Plasmodium falciparum.
de Koning-Ward TF; Waters AP; Crabb BS
Mol Biochem Parasitol; 2001 Oct; 117(2):155-60. PubMed ID: 11606225
[TBL] [Abstract][Full Text] [Related]
15. Transformation with human dihydrofolate reductase renders malaria parasites insensitive to WR99210 but does not affect the intrinsic activity of proguanil.
Fidock DA; Wellems TE
Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10931-6. PubMed ID: 9380737
[TBL] [Abstract][Full Text] [Related]
16. Stable molecular transformation of Toxoplasma gondii: a selectable dihydrofolate reductase-thymidylate synthase marker based on drug-resistance mutations in malaria.
Donald RG; Roos DS
Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11703-7. PubMed ID: 8265612
[TBL] [Abstract][Full Text] [Related]
17. Stable transformation of Toxoplasma gondii based on a pyrimethamine resistant trifunctional dihydrofolate reductase-cytosine deaminase-thymidylate synthase gene that confers sensitivity to 5-fluorocytosine.
Fox BA; Belperron AA; Bzik DJ
Mol Biochem Parasitol; 1999 Jan; 98(1):93-103. PubMed ID: 10029312
[TBL] [Abstract][Full Text] [Related]
18. Pyrimethamine and WR99210 exert opposing selection on dihydrofolate reductase from Plasmodium vivax.
Hastings MD; Sibley CH
Proc Natl Acad Sci U S A; 2002 Oct; 99(20):13137-41. PubMed ID: 12198181
[TBL] [Abstract][Full Text] [Related]
19. Analysis in yeast of antimalaria drugs that target the dihydrofolate reductase of Plasmodium falciparum.
Wooden JM; Hartwell LH; Vasquez B; Sibley CH
Mol Biochem Parasitol; 1997 Mar; 85(1):25-40. PubMed ID: 9108546
[TBL] [Abstract][Full Text] [Related]
20. Fitness effects of DHFR-TS mutations associated with pyrimethamine resistance in apicomplexan parasites.
Fohl LM; Roos DS
Mol Microbiol; 2003 Nov; 50(4):1319-27. PubMed ID: 14622418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
